Literature DB >> 24459457

Cystoid macular edema associated with acitretin.

Joel Yap1, Alex Buller1.   

Abstract

Cystoid macular edema represents a "final common pathway" response of the retina to a variety of insults. It has been reported in association with vascular problems, inflammatory conditions, inherited diseases, tractional problems, intraocular surgery and medications. We report a case of cystoid macular edema associated with acitretin in a 65-year-old woman and document its resolution with optical coherence tomography (OCT).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24459457      PMCID: PMC3899804          DOI: 10.5693/djo.02.2013.09.002

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  6 in total

1.  Acitretin-associated maculopathy.

Authors:  Noemi Lois; Marion White
Journal:  Arch Ophthalmol       Date:  2004-06

Review 2.  RPE lipofuscin and its role in retinal pathobiology.

Authors:  Janet R Sparrow; Mike Boulton
Journal:  Exp Eye Res       Date:  2005-05       Impact factor: 3.467

Review 3.  Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment.

Authors:  J H Saurat
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

Review 4.  Acitretin in psoriasis: an overview of adverse effects.

Authors:  H I Katz; J Waalen; E E Leach
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

5.  Visual toxicity of synthetic retinoids.

Authors:  R D Brown; C E Grattan
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

6.  Retinal pigment epithelium rescues vascular endothelium from retinoic acid-induced apoptosis.

Authors:  Tongalp H Tezel; Lijun Geng; Henry J Kaplan; Lucian V Del Priore
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

  6 in total
  1 in total

1.  Loratadine-associated cystoid macular edema: A case report.

Authors:  Yong Tang; Rui Dou; Yuyan Liu; Shiyong Xie; Quanhong Han
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.